发明名称 Controlled release formulations of levodopa and uses thereof
摘要 The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.
申请公布号 US9089608(B2) 申请公布日期 2015.07.28
申请号 US201314030792 申请日期 2013.09.18
申请人 Impax Laboratories, Inc. 发明人 Hsu Ann;Kou Jim H.;Alani Laman Lynn
分类号 A61K9/24;A61K9/26;A61K47/12;A61K9/16;A61K9/20;A61K9/28;A61K9/50;A61K31/137;A61K31/198;A61K45/06;C07C229/36;A61K9/00;A61K31/197;A61K47/34;A61K47/38 主分类号 A61K9/24
代理机构 Florek & Endres PLLC 代理人 Florek & Endres PLLC
主权项 1. A controlled release oral solid formulation of levodopa comprising: a. levodopa, b. a decarboxylase inhibitor, and c. a carboxylic acid that is not (a) or (b), wherein the carboxylic acid of (c) is in a distinct bead from (a) or (b).
地址 Hayward CA US